Differential effects of radical D2-lymphadenectomy and splenectomy in surgically treated gastric cancer patients

Hepato-Gastroenterology

Volumn 47, Issue 32, 2000, Pages 579-585

  Schmid, Andreas ^a   Thybusch, A ^a   Kremer, B ^a   Henne Bruns, D ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Extended lymphadenectomy; Gastric cancer; Morbidity; Splenectomy

Indexed keywords

ABSCESS; ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; FEMALE; HUMAN; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SPLENECTOMY; STOMACH CANCER; TREATMENT OUTCOME; WOUND DRAINAGE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; GASTRIC STUMP; HOSPITAL MORTALITY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM STAGING; REOPERATION; RETROSPECTIVE STUDIES; SPLENECTOMY; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0033999711     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 1 Hundahl SA, Stemmermann GN, Oishi A: Racial factors cannot explain superior Japanese outcomes in stomach cancer. Arch Surg 1996; 131:170-175.
2. 2 Maruyama K, Okabayashi K, Kinishita T: Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987; 11:418-425.
3. 3 Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K: Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 1995; 19:532-536.
4. 4 Miwa K: Treatment results of gastric carcinoma in Japan No.39 In: Japanese classification of gastric carcinoma. JRSGC. 1st English Edition. Tokyo: Kanehara & Co, 1995; pp. 1-37.
5. 5 Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JTM, van Elk P, Gouma DJ, Taat CW, van Lanschot J, Meyer S, de Graaf PW, von Meyenfeldt MF, Tilanus H, van de Velde CJH: Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345:745-748.
6. 6 Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. Lancet 1996; 347:995-999.
7. 7 Müller G: Allgemeine Richtlinien für Chirurgie und Pathologie der japanischen Magenkarzinomstudie - Japanese Research Society for Gastric Cancer. Chirurg 1995; 56:539-552.
8. 8 Böttcher K, Siewert JR, Roder JD, Busch R, Hermanek P, Meyer HJ: Risk analysis of surgical therapy for gastric cancer in Germany. Chirurg 1994; 65:298-306.
9. 9 Roder JD, Böttcher K, Siewert JR, Busch R, Hermanek P, Meyer HJ, and the German Gastric carcinoma study group: Prognostic factors in gastric carcinoma - Results of the German gastric carcinoma study 1992. Cancer 1993; 72(7):2089-2097.
10. 10 Hiller WFA, Jähne J, Meyer HJ: Impact of D2 lymphadenectomy on morbidity and long-term survival in patients with gastric cancer. Oncology 1997; 20:145-150.
11. 11 Roder JD, Bonenkamp JJ, Craven J, van de Velde CJH, Sasako M, Böttcher K, Stein HJ: Lymphadenectomy for gastric cancer in clinical trials: Update. World J Surg 1995; 19:546-553.
12. 12 Siewert JR, Bottcher K, Roder JD, Busch R, Hermanek P, Meyer HJ: Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 1993; 80:1015-1018.
13. 13 Siewert JR, Kestlmeier R, Busch R, Böttcher K, Roder JD, Müller J, Fellbaum C, Höfler H: Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 1996; 83:1144-1147.
14. 14 Baba H, Maehara Y, Takeuchi H, Inutsuka S, Okuyama T, Adachi Y, Akazawa K, Sugimachi K: Effects of lymph node dissection on the prognosis in patients with node-negative early gastric cancer. Surgery 1995; 177(2):165-169.
15. 15 Maehara Y, Tomodo M, Tomisaki S, Ohmori M, Baba H, Akazawa K, Sugimachi K: Surgical treatment and outcome for node-negative gastric cancer. Surgery 1997; 121(6):633-639.
16. 16 Baba H, Maehara Y, Inutsuka S, Takeuchi H, Oshiro T, Adachi Y, Sugimachi K: Effectiveness of extended lymphadenectomy in noncurative gastrectomy. Am J Surg 1995; 169:261-264.
17. 17 De Manzoni G, Verlato G, Gugliemi A, Laterza E, Genna M, Cordiano C: Prognostic significance of lymph node dissection in gastric cancer. Br J Surg 1996; 83:1604-1607.
18. 18 Nürnberger HR, Awwad E, Löhlein D: Is it necessary to perform a splenectomy "en principe" in radical gastrectomy with systemic lymphadenectomy in gastric carcinoma? Zentralbl Chir 1996; 121:144-147.
19. 19 Grimm H, Binmöller KF, Hamper K, Henne-Bruns D, Soehendra N: Endosonography for preoperative locoregional staging of esophageal and gastric cancer. Endoscopy 1993; 25:224-230.
20. 20 Adachi Y, Mimori K, Mori M, Maehara Y, Sugimachi K: Morbidity after D2 and D3 gastrectomy for node-positive gastric carcinoma. J Am Coll Surg 1997; 184:240-245.
21. 21 Griffith JP, Sue-Ling HM, Martin I, Dixon MF, McMahon MJ, Axon ATR, Johnston D: Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut 1995; 36:684-690.
22. 22 Okajima K, Isozaki H: Splenectomy for treatment of gastric cancer: Japanese experience. World J Surg 1995; 19:537-540.
23. 23 Otsuji E, Yamaguchi T, Sawai K, Ohara M, Takahashi T: End results of simultaneous splenectomy in patients undergoing total gastrectomy for gastric cancer. Surgery 1996; 120(1):40-44.
24. 24 Takahashi M, Fujimoto S, Kobayashi K, Takai M, Endoh F, Ohkubo H: Indication for splenectomy combined with total gastrectomy for gastric cancer: Analysis of data on 249 gastric cancer patients. Hepatogastroenterology 1995; 42:230-233.
25. 25 Kwon SJ: Prognostic impact of splenectomy on gastric cancer: Results of the Korean Gastric Cancer Study Group. World J Surg (1997) 21:837-844